Social Capital Suvretta Holdings Corp. III (DNAC) Stock Price, News & Analysis

Company Overview

Social Capital Suvretta Holdings Corp. III does not have significant operations. It focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company intends to focus on searching for a target business operating in the biotechnology industry and within the organ space sub-sector. Social Capital Suvretta Holdings Corp. III was incorporated in 2021 and is based in Henderson, Nevada.

Key Stats

• Today's Range: $9.25 to $10.50
• 50-Day Range: $8.41 to $10.00
• 52-Week Range: $8.03 to $10.55
• Volume: 8,160 shs
• Average Volume: 178,857 shs
• Market Capitalization: $237.94 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

DNAC Stock Analysis - Frequently Asked Questions

When did Social Capital Suvretta Holdings Corp. III IPO?

Social Capital Suvretta Holdings Corp. III (DNAC) raised $200 million in an initial public offering on Wednesday, June 30th 2021. The company issued 20,000,000 shares at a price of $10.00 per share.

What other stocks do shareholders of Social Capital Suvretta Holdings Corp. III own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Social Capital Suvretta Holdings Corp. III investors own include Citrix Systems (CTXS), Social Capital Suvretta Holdings Corp. I (DNAA), Social Capital Suvretta Holdings Corp. II (DNAB), Flora Growth (FLGC), Global-E Online (GLBE), iSpecimen (ISPC) and AMN Healthcare Services (AMN).

Company Calendar

• Today: 1/15/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Biological Products, Except Diagnostic
• Sub-Industry: N/A
• Current Symbol: NASDAQ:DNAC
• CUSIP: N/A
• CIK: 1850270
• Web: N/A
• Phone: 650-521-9008
• Fax: N/A
• Employees: 4
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 0.11
• Quick Ratio: 0.11

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: ($0.33) per share
• Price / Book: -28.12

Miscellaneous

• Outstanding Shares: 25,640,000
• Free Float: N/A
• Market Cap: $237.94 million
• Optionable: Not Optionable
• Beta: N/A